Shenzhen Chipscreen Biosciences Hits Day Low at CNY 27.83 Amid Price Pressure

Shenzhen Chipscreen Biosciences Co., Ltd. experienced a significant decline today, with its stock price dropping by 6.68% to reach an intraday low of CNY 27.83. This performance stands in contrast to the China Shanghai Composite, which saw a slight increase of 0.04% on the same day. Over the past week, Shenzhen Chipscreen has faced a 9.4% decrease, while its monthly performance reflects a decline of 3.55%. Year-to-date, the stock is down 4.35%, and over the past year, it has lost 26.12% of its value, despite generating a notable return of 59.27% in the last year compared to the market's 22.49%. The company operates within the Pharmaceuticals & Biotechnology sector and holds a market capitalization of CNY 12,750 million. Key financial metrics indicate a challenging environment, with a low return on capital employed (ROCE) of 0% and a negative net worth. Despite these hurdles, the company has reported some positive results, including a significant increase in pre-tax profit and net profit in recent quarters. However, the overall outlook remains cautious as the company navigates its financial landscape.